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î , r  rA R EFU L W IT H  D ISC O N TIN U A TIO N  O F T R E A T M E N T  W IT H  
WHALED C O R T IC O ST E R O ID S IN  M IL D  ASTHM A 
PM  van Grunsven*, E. D om pcling* , C .P. van  Schayck*, J . M olema**, 
R P Akkermans*, H. Folgcring**, C. van Wcel*. *Dept G eneral Prac­
tice and Social M edicine, **D ept Pulm onology, U niversity  of Nijmegen,
The Netherlands.
The a i m  o f  t h is  observational study was to investigate if long-term therapy 
with inhaled corticosteroids could be discontinued in mild asthma when 
atients were in a clinically stable phase o f the disease. Data were derived 
from a two-year randomised controlled bronchodilator intervention study in 
family practice. The experimental group consisted of 19 asthmatic patients, 
who had used inhaled corticosteroids daily during at least the year preced- 
i lhis study. The responsible physician considered the subjects to be 
able to discontinue their inhaled steroids, The control group consisted of 
the 70 patients with asthma, who had not used corticosteroids in the year 
preceding the study. After an eight week wash-out period of steroids, the 
patient characteristics of the two groups were completely comparable. Out­
come measures were: drop-outs because of dependency of corticosteroids, 
the a n n u a l decline in forced expiratory volume in one second (FEV^), an­
nual change in nonspecific bronchial responsiveness (PC2 o*bistamine), 
e x a c e rb a t io n s , and symptoms. In the experimental group, 12 of the 19 
patients (63%) dropped out during the study because o f  dependency of 
corticosteroids. In the control group, only 8 patients dropped out for this 
reason (11%). This difference was significant (Chi-square =* 20 .1 , 
p * jj,Ü Ö Ü l) . In the patients of the experimental group (who continued not 
using inhaled steroids during at least 12 months) the annual FEVj decline 
was much larger than in the control subjects (165 versus 40 tnl/yr, 
p=0.022). From these secondary analyses it was concluded that s topp ing  
maintenance treatment with inhaled corticosteroids is not advisable in all 
patients with mild asthma.
P1594
IS IT  C O R RECT TO MEASURE REVERSIBILITY T O  ß2-AGONIST 
SHORTLY AFTER QUANTIFYING AIRWAY RESPONSIVENESS?
I. Steffensen, V. Backer. D epartm ent of Pulm onary M edicine P, U niver­
sity Hospital Bispebjerg, Copenhagen, Denmark.
Aim: To evaluate the validity of measuring reversibility to ß 2 -agonist (ß2 T)
30 minutes after quantifying airway responsiveness (BR).
Patients: 12 patients aged 18-70 years with certain asthma, defined as 1) a 
history of asthma with daily use of steroids and ß 2 *agonist, 2) reversibility 
of more than 15% in forced expiratory volume over 1 second (FEVj) 15 
minutes after inhalation of ß2 -agonist (2,5 mg terbutaline) and 3) a fall o f 
more than 20% in FEV \ after inhalation of less than 8 jxmol histamine. 
M ethods: Patients were examined three times at the outpatient clinic, i.e., 
twice with ß2 T alone, and once with BR+ß2 T. All patients were randomized 
to one of the following sequences: 1) BR+ß2 T, ß2 T, ß 2 T, 2) ß 2 T, 
BR+ß2 T, ß2 T or 3) p2 T. ß 2 T, BR+ß2 T. BR was performed in accordance 
with the method described by YAN using histamine to a maximum of 7 ,8  
pmol administrated by DeVilbiss No, 40 hand-held jet nebulizers. During 
ß jT , 2,5 mg terbutaline was given. Following BR, ß2 T was performed 3 0 
minutes after the last inhalation of histamine when the lung function was at 
least 75% of baseline FEVj,
Results: All patients demonstrated a significant reversibility to p 2 -agonist 
of more than 15%, both after histamine provocation, and when done alone. 
There was no significant difference in the reversibility test performed after the 
BR as compared to the reversibility measured alone.
Conclusion: The effect of ß 2 *agonist can be evaluated 30 minutes after 
measuring airway responsiveness without getting any false over- or underes­
timated reversibility.
Notes
